Fed’s Powell opens door to potential rate cuts at Jackson Hole
On Wednesday, Morgan Stanley (NYSE:MS) analysts reiterated an Equalweight rating on Universal Health Services (NYSE:UHS) stock, maintaining a price target of $200.00. The decision follows a virtual fireside chat with the company’s CFO, Steve Filton, as part of the firm’s ongoing C-Suite series of calls. The company, currently valued at $12.2 billion, has demonstrated strong financial performance with a 9.7% revenue growth over the last twelve months.
The discussion with Filton highlighted solid utilization trends in the acute business, with growth in the behavioral sector leaning more toward price adjustments. Morgan Stanley noted that Universal Health Services has underperformed compared to its peers, suggesting potential for a catchup trade. According to InvestingPro, the company maintains a "GREAT" overall financial health score, supported by strong profitability metrics and consistent dividend payments for 23 consecutive years.
Universal Health Services is trading toward the lower end of its valuation range, according to Morgan Stanley. The analysts pointed out that the stock’s performance relative to peers has been notably weaker, and policy impacts appear to be less severe, making the risk/reward scenario more appealing. The stock currently trades at an attractive P/E ratio of 10.2, and InvestingPro analysis suggests the stock is undervalued based on its Fair Value model.
Morgan Stanley’s analysts emphasized the importance of volume trends in the behavioral segment and policy outcomes for the company’s future performance. The firm continues to monitor these factors closely. Management has been actively returning value to shareholders through aggressive share buybacks, one of several positive indicators identified in InvestingPro’s comprehensive analysis of over 100 financial metrics.
For additional insights into Universal Health Services’ first-quarter earnings, Morgan Stanley referred to a previous report titled "Noisy print relative to peers; remain Equalweight."
In other recent news, Universal Health Services reported its first-quarter 2025 earnings, with earnings per share (EPS) of $4.80, exceeding the forecast of $4.36. The company, however, fell short on revenue, bringing in $4.1 billion compared to the anticipated $4.16 billion. Despite this, Universal Health Services maintained its full-year earnings guidance, indicating confidence in its financial outlook. In another development, the company declared a quarterly cash dividend of $0.20 per share, payable to shareholders on June 16, 2025. This move underscores its commitment to returning value to shareholders.
Cantor Fitzgerald recently reaffirmed a Neutral rating on Universal Health Services, maintaining a price target of $227.00. Analyst Sarah James noted staffing challenges in several cities but highlighted improvements in inpatient psychiatric care metrics. The company has not publicly responded to these observations. Investors are also keeping an eye on Universal Health Services’ ongoing efforts to manage operating expenses effectively, which contributed to a 21% increase in EBITDA for the quarter. These developments continue to shape investor perspectives on the company’s performance and strategic direction.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.